LRIG2 and cancer: The expression of the human leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins LRIG1, LRIG2, and LRIG3 has emerged as a new potential prognostic biomarker in different types of human cancer, including cervical cancer [18].